Publication date: Sep 28, 2020 Few studies have estimated the probability of being cured for cancer patients. This study aims to estimate population-based indicators of cancer cure in Europe by ... Read more

Publication date: Sep 28, 2020 Extracellular adenosine, produced through the activity of the ecto-5′-nucleotidase CD73, elicits potent immune-suppressive effects and its upregulation in tumor cells as well as in stromal ... Read more

Publication date: Sep 28, 2020 Dermatoscopy is a non-invasive tool that increases the accuracy of non melanoma skin cancer (NMSC) diagnosis. Dermoscopic features of basal cell carcinoma (BCC) and cutaneous ... Read more

Publication date: Sep 28, 2020 Immune checkpoint blockade (ICB) therapy has demonstrated considerable clinical benefit in several malignancies, but has shown favorable response in only a small proportion of cancer ... Read more

Publication date: Sep 28, 2020 Fear of cancer recurrence (FCR) may be debilitating, yet knowledge of FCR among the growing population of long-term young adult cancer survivors (YACS) is scarce. ... Read more

Publication date: Sep 29, 2020 Our aim was to assess the long-term clinical outcome of boron neutron capture therapy (BNCT) using 10B-para-boronophenylalanine (BPA) as the boron delivery agent for cutaneous ... Read more

Publication date: Sep 29, 2020 Germline mutations in CDKN2A greatly increase risk of developing cutaneous melanoma. We have constructed a risk prediction model, Familial Risk Assessment of Melanoma (FRAMe), for ... Read more

Publication date: Sep 29, 2020 The Eph (erythropoietin-producing human hepatocellular) receptors form the largest known subfamily of receptor tyrosine kinases. These receptors interact with membrane-bound ephrin ligands via direct cell-cell ... Read more